A combination of Bayer AG's antibiotic moxifloxacin -- in place of an older drug -- with standard tuberculosis drugs may reduce the length of treatment by at least two months, researchers reported. Experts believe that speeding up the six-month therapy can help TB patients follow their prescribed regimens and prevent or reduce the development of drug-resistant strains.

Full Story:

Related Summaries